10X Genomics Inc (TXG) — Working Capital to Net Assets Ratio
10X Genomics Inc (TXG) has a Working Capital to Net Assets ratio of 67.4% as of June 2026. Working capital of $556.16 Million (current assets of $674.67 Million minus current liabilities of $118.51 Million) is measured against net assets of $825.55 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See 10X Genomics Inc (TXG) defensive interval to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
10X Genomics Inc Working Capital to Net Assets (2017–2025)
This chart shows how 10X Genomics Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 67.4%, reflecting working capital of $556.16 Million against net assets of $825.55 Million USD. For the complete balance sheet picture, see 10X Genomics Inc asset portfolio.
Annual Working Capital to Net Assets for 10X Genomics Inc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for 10X Genomics Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 10X Genomics Inc liquidity resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 66.7% | $531.00 Million | $796.33 Million | $684.45 Million | $153.45 Million | ▲ +1.0 pp |
| 2024 | 65.7% | $466.75 Million | $710.13 Million | $584.39 Million | $117.63 Million | ▲ +2.5 pp |
| 2023 | 63.3% | $468.86 Million | $741.04 Million | $596.02 Million | $127.16 Million | ▲ +0.7 pp |
| 2022 | 62.6% | $504.08 Million | $805.74 Million | $635.03 Million | $130.96 Million | ▼ -15.4 pp |
| 2021 | 77.9% | $637.23 Million | $817.57 Million | $747.59 Million | $110.36 Million | ▼ -10.8 pp |
| 2020 | 88.8% | $656.24 Million | $739.07 Million | $774.37 Million | $118.13 Million | ▼ -10.7 pp |
| 2019 | 99.5% | $417.79 Million | $420.08 Million | $480.84 Million | $63.05 Million | ▲ +133.0 pp |
| 2018 | -33.6% | $73.87 Million | $-219.99 Million | $106.24 Million | $32.36 Million | ▲ +7.3 pp |
| 2017 | -40.9% | $45.97 Million | $-112.51 Million | $68.11 Million | $22.14 Million | — |